Pathway's PVD revascularization catheter gets FDA nod

The FDA has granted Pathway Medical Technologies' 510(k) clearance to market Jetstream Navitus, an updated revascularization catheter for the treatment of peripheral vascular disease (PVD).

The Jetstream Navitus is an option for treating calcium blockages and chronic total occlusions in the PVD patient population. The device offers active aspiration, which allows the operator to continually aspirate excised tissue and thrombus while the device is operating, according to Kirkland, Wash.-based company

The Jetstream Navitus is now available for sale throughout the U.S.

Around the web

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.